Alphacholine
Drugs influencing the nervous system. Parasympathomimetics. Choline alfoscerateRelease forms:
- Solution for injection
- Oral solution
Acute period of severe traumatic brain injury with predominantly stem level of damage (disturbance of consciousness, coma, focal hemispheric symptoms, symptoms of brain stem damage).
Degenerative-involutional cerebral psychoorganic syndromes or secondary consequences of cerebrovascular insufficiency, i.e. primary and secondary mental disorders in the elderly, characterized by memory impairment, confusion, disorientation, decreased motivation and initiative, decreased ability to concentrate; changes in the emotional sphere and the sphere of behavior: emotional instability, irritability, indifference to the environment; pseudomelancholia in the elderly.
Characteristics of the productу:
Release formInjectable solution
PregnantContraindicated
NursingContraindicated
Release categoryPrescription medication
DriversAllowed
Temperature storage conditionsNot higher than 25 °С
- Qualitative and quantitative composition:
- Pharmaceutical form
- Pharmacotherapeutic group
- Pharmacological properties
- Clinical particulars
- Therapeutic indications
- Contraindications
- Interaction with other medicinal products and other forms of interaction.
- Posology and method of administration
- Overdose
- Undesirable effects
- Shelf life
- Special precautions for storage
- Incompatibilities
- Nature and contents of container
- Category of release
- Manufacturer
- The manufacturer's location and address of the place of business
- Date of last revision